The debate over the true cost of developing new drugs has created a virtual cottage industry of analysis in recent years. Critics maintain that the pharma industry has wildly overblown costs to
Research scientist Derek Lowe has taken to his blog over at In The Pipeline to have some fun with a recent estimate that new drugs are being developed for the bargain-basement rate of $55 million.
How much does it cost to bring a new drug to market? Tufts set out a few years ago to answer that question, and came back with $802 million in 2000, or roughly a billion dollars in today's
If you asked just about any biopharma exec on this side of the Atlantic if U.S. developers are more productive than their European colleagues, chances are you'd get a good laugh. Everybody knows that
Continuing on its deal-making quest, Pfizer has signed an agreement with Exton, PA-based Adolor for ADL5859 and ADL5747. The two pain drugs
Sanofi Pasteur is buying into Acambis' program for a novel West Nile vaccine.
GTx has scored a rich deal for partnering with Merck on developing a new class of selective androgen receptor modulators for
Tolerx has scored a Big Pharma partner in its race to develop a monoclonal antibody (MAb) that may protect people from
Microbia is pocketing a $70 million up front payment from Forest Laboratories in exchange for a 50/50 U.S. development pact for linaclotide, an experimental therapy for irritable bowel syndrome and
Faced with the Phase III failure of Desmoteplase for stroke in June, Forest Laboratories has bailed on its